| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.28 | 5e-09 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.19 | 9e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |